Renee P Tannenbaum - Net Worth and Insider Trading

Renee P Tannenbaum Net Worth

The estimated net worth of Renee P Tannenbaum is at least $2 Million dollars as of 2024-11-10. Renee P Tannenbaum is the Director of ANI Pharmaceuticals Inc and owns about 18,211 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $1 Million. Renee P Tannenbaum is the Director of Zogenix Inc and owns about 32,567 shares of Zogenix Inc (ZGNX) stock worth over $868,888. Renee P Tannenbaum is also the Director of Sharps Compliance Corp and owns about 18,436 shares of Sharps Compliance Corp (SMED) stock worth over $161,315. Besides these, Renee P Tannenbaum also holds Cardiff Oncology Inc (CRDF) . Details can be seen in Renee P Tannenbaum's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Renee P Tannenbaum has not made any transactions after 2024-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Renee P Tannenbaum

Renee P Tannenbaum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Renee P Tannenbaum owns 4 companies in total, including Zogenix Inc (ZGNX) , Sharps Compliance Corp (SMED) , and ANI Pharmaceuticals Inc (ANIP) among others .

Click here to see the complete history of Renee P Tannenbaum’s form 4 insider trades.

Insider Ownership Summary of Renee P Tannenbaum

Ticker	Comapny	Transaction Date	Type of Owner
ZGNX	Zogenix Inc	2021-11-29	director
SMED	Sharps Compliance Corp	2012-03-16	director
ANIP	ANI Pharmaceuticals Inc	2024-05-16	director
		2022-09-15	director

Renee P Tannenbaum Latest Holdings Summary

Renee P Tannenbaum currently owns a total of 4 stocks. Among these stocks, Renee P Tannenbaum owns 18,211 shares of ANI Pharmaceuticals Inc (ANIP) as of May 16, 2024, with a value of $1 Million and a weighting of 51.42%. Renee P Tannenbaum owns 32,567 shares of Zogenix Inc (ZGNX) as of November 29, 2021, with a value of $868,888 and a weighting of 39.78%. Renee P Tannenbaum also owns 18,436 shares of Sharps Compliance Corp (SMED) as of March 16, 2012, with a value of $161,315 and a weighting of 7.39%. The other 1 stocks Cardiff Oncology Inc (CRDF) have a combined weighting of 1.41% among all his current holdings.

Latest Holdings of Renee P Tannenbaum

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ANIP	ANI Pharmaceuticals Inc	2024-05-16	18,211	61.67	1,123,072
ZGNX	Zogenix Inc	2021-11-29	32,567	26.68	868,888
SMED	Sharps Compliance Corp	2012-03-16	18,436	8.75	161,315
CRDF	Cardiff Oncology Inc	2022-09-15	10,000	3.08	30,800

Holding Weightings of Renee P Tannenbaum

Renee P Tannenbaum Form 4 Trading Tracker

According to the SEC Form 4 filings, Renee P Tannenbaum has made a total of 1 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 2,000 shares on May 16, 2024, which brought Renee P Tannenbaum around $127,740.

According to the SEC Form 4 filings, Renee P Tannenbaum has made a total of 2 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zogenix Inc is the sale of 5,305 shares on November 29, 2021, which brought Renee P Tannenbaum around $62,175.

According to the SEC Form 4 filings, Renee P Tannenbaum has made a total of 0 transactions in Sharps Compliance Corp (SMED) over the past 5 years. The most-recent trade in Sharps Compliance Corp is the acquisition of 10,000 shares on March 16, 2012, which cost Renee P Tannenbaum around $38,400.

More details on Renee P Tannenbaum's insider transactions can be found in the Insider Trading History of Renee P Tannenbaum table.

Insider Trading History of Renee P Tannenbaum

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Renee P Tannenbaum Trading Performance

GuruFocus tracks the stock performance after each of Renee P Tannenbaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renee P Tannenbaum is -8.52%. GuruFocus also compares Renee P Tannenbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renee P Tannenbaum within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Renee P Tannenbaum's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Renee P Tannenbaum

Average Return

Average return per transaction

Outperforming Transactions

2 out of 4 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-4.46
Relative Return to S&P 500(%)	-1.18

Renee P Tannenbaum Ownership Network

Ownership Network List of Renee P Tannenbaum

No Data

Ownership Network Relation of Renee P Tannenbaum

Renee P Tannenbaum Owned Company Details

What does Zogenix Inc do?

Who are the key executives at Zogenix Inc?

Renee P Tannenbaum is the director of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .

Zogenix Inc (ZGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zogenix Inc Insider Transactions

No Available Data

What does Sharps Compliance Corp do?

Who are the key executives at Sharps Compliance Corp?

Renee P Tannenbaum is the director of Sharps Compliance Corp. Other key executives at Sharps Compliance Corp include 10 percent owner Raven Buyer, Inc. , 10 percent owner Raven Houston Merger Sub, Inc. , and 10 percent owner Aurora Equity Partners Vi-a L.p. .

Sharps Compliance Corp (SMED) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sharps Compliance Corp (SMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sharps Compliance Corp (SMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sharps Compliance Corp (SMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sharps Compliance Corp Insider Transactions

No Available Data

What does ANI Pharmaceuticals Inc do?

Who are the key executives at ANI Pharmaceuticals Inc?

Renee P Tannenbaum is the director of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include SR. VP & GENERAL COUNSEL & SEC. Meredith Cook , director & HEAD OF R&D & COO-NOVITIUM OPS Muthusamy Shanmugam , and SVP - CORP. DEV. & STRATEGY Chad Gassert .

ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary

Over the past 18 months, Renee P Tannenbaum made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 776,190 shares made by Muthusamy Shanmugam , a net sale of 3,000 shares made by Meredith Cook , and a net sale of 200,000 shares made by Chad Gassert .

In summary, during the past 3 months, insiders sold 750 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 750 shares. During the past 18 months, 1,411,262 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,411,262 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

ANI Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cardiff Oncology Inc do?

Who are the key executives at Cardiff Oncology Inc?

Renee P Tannenbaum is the director of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .

Cardiff Oncology Inc (CRDF) Insider Trades Summary

Over the past 18 months, Renee P Tannenbaum made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace ,

In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 52,950 shares were bought by its insiders, resulting in a net purchase of 52,950 shares.

Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cardiff Oncology Inc Insider Transactions

No Available Data

Renee P Tannenbaum Mailing Address

Above is the net worth, insider trading, and ownership report for Renee P Tannenbaum. You might contact Renee P Tannenbaum via mailing address: 9220 Kirby Drive, Suite 500, Houston Tx 77054.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.